Its long-term safety is simply not yet established, because it remains investigational
In this blog, well explore the link between diabetes and sweating, why it happens, and what you can do to manage it
Gastrointestinal effects: the main titration bottleneck Nausea, diarrhea, constipation, and vomiting run around 40 to 44% overall, dose-dependent in how many people report them but mild-dominant in severity: severe events stay at or below about 1.7% in any category even at the top dose. In the obesity program the by-dose rates run nausea 25/29/28%, diarrhea 19/21/23%, and vomiting 8/11/13% at 5/10/15 mg. They concentrate during escalation and ease with time on a held dose
743 , L16 (2011)
Trong , da trn thang nh gi mi quan h nhn qu gia thuc v bin c bt li ca WHO, 3 trng hp c xc nh c mi lin quan mc C th vi liraglutid, 26 trng hp khng th nh gi do thiu d liu